C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2011
11/16/2011	EP2386634A1 Sterol side chain-cleaving enzyme protein and use thereof
11/16/2011	EP2103630B1 Preparation of low bleeding anticoagulant fusion protein and its use
11/16/2011	CN1944644B Process for preparing HIV-lgp120 and human gamma-interferon fusion protein
11/16/2011	CN102246041A Immobilization substrate and method for producing the same
11/16/2011	CN102245764A Hybrid alpha-amylases
11/16/2011	CN102245642A Conjugates of GLP-1 agonists and uses thereof
11/16/2011	CN102245626A Mini-hepcidin peptides and methods of using thereof
11/16/2011	CN102242126A T1R taste receptors and genes encoding same
11/16/2011	CN102241778A PPA-linker-Thanatin fusion protein and preparation method thereof
11/16/2011	CN102241777A Targeted PTEN gene composite, and preparation method and application thereof
11/16/2011	CN102241776A RANKL-TNF (Receptor Activator of Nuclear Factor Kappa-B Ligand-Tumour Necrosis Factor) sample region fusion protein and preparation method and application thereof
11/16/2011	CN101121753B Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell
11/15/2011	US8058398 Modified G-CSF polypeptide
11/15/2011	US8058012 Five-helix protein
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2257851C Modulators of tissue regeneration
11/12/2011	CA2740237A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/10/2011	WO2011139854A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
11/10/2011	WO2011139853A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
11/10/2011	WO2011120013A9 Vista regulatory t cell mediator protein, vista binding agents and use thereof
11/10/2011	WO2011071280A3 Intracelluar targeting bipodal peptide binder
11/10/2011	WO2011071279A3 Bpb-based cargo delivery system
11/10/2011	WO2011047047A3 Composites containing polypeptides attached to polysaccharides and molecules
11/10/2011	US20110275134 Arrestin Biosensor
11/10/2011	US20110275107 Long wavelength engineered fluorescent proteins
11/10/2011	US20110274747 C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
11/10/2011	US20110274711 Hla-g polypeptides and pharmaceutical uses thereof
11/10/2011	US20110274658 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP1513554B9 Cd16a binding proteins and use for the treatment of immune disorders
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1313769B2 Antibodies to human il-1 beta
11/09/2011	EP1001815B1 Vectors derived from antibodies for transferring substances into cells
11/09/2011	CN102239183A Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
11/09/2011	CN102234657A Fusion protein for resisting chicken coccidiosis, preparation and application thereof
11/09/2011	CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote
11/09/2011	CN102234316A Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof
11/08/2011	US8053558 Dendritic cell co-stimulatory molecules
11/08/2011	US8053414 Methods of using B7-DC molecules to induce or enhance an immune response
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053233 Host cells expressing IL-18 receptors
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	CA2636075C Chimaeric fusion protein with superior chaperone and folding activities
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules
11/03/2011	WO2011137243A2 Fluorescent fusion polypeptides and methods of use
11/03/2011	WO2011136506A2 Method for producing recombinant complex antigens using nanoparticles of human rotavirus
11/03/2011	WO2011136361A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/03/2011	WO2011134471A1 Peptide conjugates of glp-1 receptor agonists and gastrin and their use
11/03/2011	WO2011066285A3 Peptide-based treatment for neurodegenerative diseases
11/03/2011	US20110269938 Amyloid-beta peptide crystal structure
11/03/2011	US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions
11/03/2011	US20110268737 Hla-g proteins and pharmaceutical uses thereof
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268661 Fluorescent fusion polypeptides and methods of use
11/03/2011	CA2793715A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/02/2011	EP2383342A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2381958A1 Potato virus a coat protein-based vaccine for treating melanoma and its use
11/02/2011	EP2381952A2 Sparc binding peptides and uses thereof
11/02/2011	EP2381788A2 Targeted cryptosporidium biocides
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1299522B1 Alteration of cell membrane
11/02/2011	CN1629185B Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	CN102228688A OmpC-HBsAg (Outer membrane protein Complex-Hepatitis B surface Antigen) 'a' chimeric epitope therapeutic vaccine for hepatitis B
11/01/2011	US8048986 Reversed mammalian protein-protein interaction trap
11/01/2011	CA2221192C Embedded expression of heterologous proteins
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
10/2011
10/27/2011	WO2011133493A2 Allosteric regulation of kinase activity
10/27/2011	WO2011068853A3 TREATMENT OF IgE-MEDIATED DISEASE
10/27/2011	WO2011055897A3 Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same
10/27/2011	WO2011053065A3 Catechol polyethylene glycol derivative and protein or peptide conjugates, and method for preparing same
10/27/2011	WO2011038149A3 Methods of treating inflammation
10/27/2011	US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011	US20110263835 Recombinant nell protein production
10/27/2011	US20110263689 AKT Ligands and Polynucleotides Encoding AKT Ligands
10/27/2011	US20110263487 Plant Production and Delivery System for Recombinant Proteins as Protein-Flour or Protein-Oil Compositions
10/27/2011	US20110262479 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/27/2011	US20110262478 Recombinant Protein Bodies as Immunogen-Specific Adjuvants
10/27/2011	US20110262477 Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
10/27/2011	US20110262474 Chimeric HIV Antigens
10/27/2011	US20110262466 Compositions containing thrombomodulin domains and uses thereof
10/27/2011	US20110262394 Dna constructs eliciting immune response against flavivirus and effective adjuvants
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/26/2011	EP2380979A1 Protein substance having triple helix structure and manufacturing method therefor
10/26/2011	EP2380914A1 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminal end of ec-sod
10/26/2011	EP2380902A1 Protein layers and their use in X-ray crystallography
10/26/2011	EP1692158B1 Vegf binding and supported peptides for treating skin diseases
10/26/2011	EP1427837B1 Modular transfection systems based on nucleoprotein filaments
10/26/2011	CN102225968A Recombinant anguilla marmorata follicle stimulating hormone FSH beta alpha and preparation method and application thereof
10/26/2011	CN101638440B Heterogenetic antigen-Fc fusion protein capable of inducing antitumor immunity of organism and application thereof
10/25/2011	US8044183 Process for the production of immunogenic compositions
10/25/2011	US8044174 Thrombopoietic compounds
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043608 Methods of using Fc-cytokine fusion proteins
10/25/2011	CA2712304C Recombinant chimeric proteins and methods of use thereof
10/25/2011	CA2437866C Novel clock gene bmal2
10/25/2011	CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof

1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 295